Skip to content
← Full study record

NCT00061945 · MORE INFO

Limitations, agreements, and source contact

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia · Source last updated 2022-05-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
wstock@medicin.bsd.uchicago.edu
organization
University of Chicago Medical Center
title
Wendy Stock, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
wstock@medicin.bsd.uchicago.edu
organization
University of Chicago Medical Center
title
Wendy Stock, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice